HEOR Evidence Synthesis Director

About the Department

The Clinical, Medical and Regulatory (CMR) department at Novo Nordisk is one of the most diverse and collaborative groups within the organization. From healthcare provider interactions and developing and implementing regulatory strategies with the FDA to providing medical education and collecting data to support efficacy and new product development, CMR is involved. The one thing that keeps us all marching to the same beat is our patient centered focus. At Novo Nordisk, you will help patients around the world. As their needs evolve, so does our challenge to find better and more innovative ways to improve their quality of life. We’re changing lives for a living. Are you ready to make a difference?

The Position

The Director, HEOR Evidence Synthesis is part of the HEOR Evidence Synthesis and Strategy (HEOR-ESS) sub-team and serves as the HEOR evidence synthesis lead ensuring that HEOR evidence generated internally and externally is leveraged to support pre-launch, launch and life-cycle management of therapies. The HEOR-ESS sub-team is part of a larger Clinical Data Science and Evidence (CDSE) team which sits within the CMR department. The mission of the HEOR-ESS team is to develop the HEOR evidence strategy that corresponds with the strategy of the larger organization and synthesize and disseminate impactful real-world evidence generated by the RWE and modeling teams within CDSE. The Director, HEOR Evidence Synthesis is responsible to work closely with the HEOR Strategy Director to ensure that stakeholder evidence needs (RWE or modeling) are incorporated in the HEOR strategy and evidence generated and referenced internally and externally is scientifically rigorous and aligned to NNI strategy throughout product life cycle.  In addition, the Director, HEOR synthesis will monitor and engage with external bodies such as ICER, conducting health technology reviews of NNI products in the US.  The incumbent will also serve as an internal reviewer/approver of research protocols as well as enable pull-through of synthesized evidence being developed for proactive and reactive communication with external customers, including materials for proactive promotion as well as reactive medical exchange. In addition, the incumbent will lead the execution and dissemination of any rapid data analytics requests from stakeholders to support their internal strategy.

The Director, HEOR Evidence Synthesis will work with high visibility within a matrixed environment at NNI alongside HEOR Strategy, Market Access, Medical Affairs, Real-World Evidence teams and Clinical Development to and lead the conceptualization and delivery of the Evidence Synthesis Package and other creative evidence deliverables as needed by stakeholders.  This individual will be a collaborator for research within specific therapeutic areas and is accountable for study specific pull through and dissemination activities including but not limited to too development timelines, budget, deliverables, and training, all while complying with Novo Nordisk policies and procedures. The key deliverable for this role will be the synthesis and dissemination of evidence that is compelling to decision makers and are aligned with NNI evidence needs and research strategy.

Relationships

This position reports to the Senior Director, HEOR Evidence Strategy and Synthesis. The Director, HEOR Evidence Synthesis works in tandem with the HEOR Strategy Director and very closely with a number of NNI functions including Clinical Development, Medical Affairs, Real World Evidence teams,  Legal, Regulatory, Market Access and Public Affairs, Marketing and Sales, and other key internal stakeholders.  In the execution of specific projects, the Director, HEOR Evidence Synthesis will work within the NNI cross-functional project team to provide scientific expertise to the research protocol and analysis plan and interpret results with the external customer in mind. Throughout the conduct of research, this individual will take the lead on all aspects of communication and dissemination associated with the research activity.

Essential Functions

• The incumbent must understand the US market landscape, external stakeholder needs, and how these culminate into an HEOR strategy. In addition, she/he must work in tandem with the HEOR Strategy Director and lead communication activities in the areas of RWE and HEOR
• Develop institutional knowledge of internal stakeholders who utilize RWE, economic models, and rapid data analytics and develop pathways such that the impact from the evidence is timely and tailored to the needs of the customer-facing team
• Provide communication expertise working alongside advocates from medical and commercial teams and in partnership with others within the HEOR-ESS team, and oversee the dissemination of all HEOR & RWE studies for the portfolio of therapeutic areas
• Actively seek and display understanding of therapeutic area/Brand strategy, and map strategy to research conduct and output
• Develop understanding of needs of each existing internal and external customer and monitor gaps in overall value of the Brand/s and relative value in the market
• Work with key internal stakeholders to ensure that research studies are aligned with the needs of the internal stakeholders and external customers
• Develop & solidify pathway for use of evidence in promotional situations and connected to medical communication
• Continually communicate with internal stakeholders while synthesizing evidence across the therapeutic area to ensure and increase visibility and use of the team’s work
• Design Evidence Synthesis Package and other tools and materials based on the research for Novo Nordisk internal communication and also, when applicable, for external communications by Field Medical Affairs and other functions including Market Access & Public Affairs and Marketing functions
• Function as a key partner during research execution, coordination of converting research output to customer facing messaging, and reviews of reactive and promotional pieces by internal review teams, within assigned therapeutic areas
• The incumbent will have a proven track record of strong methodological expertise in addition to impeccable stakeholder management and negotiation skills
• The incumbent will also possess experience in successfully navigating organizational dynamics and effectively championing outside-of-the-box ideas
• The individual in this role must also be a quintessential team-player, due to the team-based nature of this type of research

Physical Requirements

10-20% overnight travel required. Position is home office based in Princeton, NJ. 

Qualifications

• A PhD or Masters/MD/PharmD degree in appropriate healthcare-related field (heath economics, epidemiology, outcomes research, public health, business/health services research, biostatistics, medicine, biomedical sciences) preferred
• Excellent knowledge and experience in conducting health economics, health services research studies, real world research and the evaluation of health care interventions
• At least 5 years of experience in health economics, outcomes research, pricing, reimbursement, medical affairs, and/or portfolio analysis, with at least 2 years in the pharmaceutical industry, payor or healthcare
• Keen knowledge of health care systems in the U.S., including managed care organizations, integrated health systems, PBMs, Medicare, and Medicaid
• Strong knowledge of healthcare big data and applications
• Demonstrated track record of peer-reviewed scientific publications, dossier development, and strategic, customer-focused HEOR tool development
• Experience in preparing, reviewing and presenting materials to drug formularies and other customers strongly preferred
• Proven record of outstanding written and verbal communication and negotiation skills, with experience interacting with and presenting to key customers

The base compensation range for this position is $240,000 to $275,000. Base compensation is determined based on a number of factors. This position is also eligible for a company bonus based on individual and company performance.   

Novo Nordisk offers long-term incentive compensation and or company vehicles depending on the position's level or other company factors.   

  
Employees are also eligible to participate in Company employee benefit programs including medical, dental and vision coverage; life insurance; disability insurance; 401(k) savings plan; flexible spending accounts; employee assistance program; tuition reimbursement program; and voluntary benefits such as group legal, critical illness, identity theft protection, pet insurance and auto/home insurance. The Company also offers time off pursuant to its sick time policy, flex-able vacation policy, and parental leave policy.

We commit to an inclusive recruitment process and equality of opportunity for all our job applicants.

At Novo Nordisk, we're not chasing quick fixes – we're creating lasting change for long-term health. For over 100 years, we've been driven by a single purpose: to defeat serious chronic diseases and help millions of people live healthier lives. This dedication fuels our constant curiosity and inspires us to push the boundaries of what's possible in healthcare. We embrace diverse perspectives, seek out bold ideas, and build partnerships rooted in shared purpose. Together, we're making healthcare more accessible, treating and defeating diseases, and pioneering solutions that create change spanning generations. When you join us, you become part of something bigger – a legacy of impact that reaches far beyond today.

Novo Nordisk is an equal opportunity employer. Qualified applicants will receive consideration for employment without regard to race, ethnicity, color, religion, sex, gender identity, sexual orientation, national origin, disability, protected veteran status or any other characteristic protected by local, state or federal laws, rules or regulations.

If you are interested in applying to Novo Nordisk and need special assistance or an accommodation to apply, please call us at 1-855-411-5290. This contact is for accommodation requests only and cannot be used to inquire about the status of applications.